Leaky blood vessels behind Long Covid-linked brain fog, says study

In a major discovery, a team of scientists discovered disruption to the blood vessels in the brains of patients suffering from Long Covid and ‘brain fog’. The team from Trinity College Dublin showed that this blood vessel “leakiness” was able to objectively distinguish those patients with brain fog and cognitive decline compared to patients suffering from Long Covid but not with brain fog.

One in nine adults in US experience Long Covid: CDC

One in nine adults in the US who have ever had Covid-19 continue to experience Long Covid with a wide range of symptoms, according to new data of the Centers for Disease Control and Prevention (CDC). To bolster Long Covid research efforts, the US National Institutes of Health (NIH) announced on Tuesday that it is investing an additional $515 million over the next four years into the Researching Covid to Enhance Recovery (RECOVER) Initiative, a nationwide research program to fully understand, diagnose and treat Long Covid.

Pfizer’s Paxlovid antiviral drug does not reduce risk of long Covid: Study

US pharma giant Pfizer’s antiviral drug Paxlovid (Nirmatrelvir-ritonavir) does not reduce the risk of developing long Covid for vaccinated, non-hospitalised individuals, according to a study.

A team of researchers from the University of California San Francisco (UCSF) revealed that among Paxlovid users, a higher proportion of individuals with acute symptoms rebound and test-positivity than previously reported.

ATEA, IITStartups, CAStartups, FalconX, legal firm collaborated to boost early stage startups

Overcoming recession concerns, several Indian American entrepreneurial accelerators, service providers, and investors with an objective to work in a collaborative way to boost startups, attended the year’s first networking event on January 21 at FalconX in Milpitas, California. The main host was the American Tamil Entrepreneurs Association (ATEA), a non-profit organization.

Affordable novel nanotechnology approaches could help unvaccinated populations with COVID-19

Ritu Jha- Jayakumar Rajadas, director of the Regenerative Biomaterials Lab (ADDReB) at Stanford University, works on developing therapeutic, and vaccine solutions aimed mainly toward helping people who are either unable to access or take the COVID-19 vaccine for medical reasons. In an interview with indica, Rajadas said that when he first began addressing the problem […]